The educational series will continue in 2026. Stay tuned for further updates.
Learning objectives:
-
Deepening knowledge on state-of-the-art strategies for diagnosis and screening of heart failure with preserved ejection fraction (HFpEF)
-
Understanding unmet needs in the management of HFpEF, chronic kidney disease and Type 2 Diabetes
-
Becoming familiar with strategies to reduce cardiovascular and renal complications in diabetes
-
Learning about the role of non-steroidal MRAs in the latest treatment recommendations of the management
on CKD in Type 2 Diabetes, including ADA, KDIGO and the focused update of the ESC Heart failure Guidelines 2023 - Translating guidelines into the daily clinical care
-
Deepening knowledge about outcomes of FINEARTS-HF, FIDELIO-DKD, FIGARO-DKD and FIDELITY
-
Understanding current treatment approaches and learning about potential future therapies of chronic heart failure, including non-steroidal MRAs
- Optimizing interfaces between cardiologists, nephrologists, diabetologists and primary care physicians
Deepening knowledge on state-of-the-art strategies for diagnosis and screening of heart failure with preserved ejection fraction (HFpEF)
Understanding unmet needs in the management of HFpEF, chronic kidney disease and Type 2 Diabetes
Becoming familiar with strategies to reduce cardiovascular and renal complications in diabetes
Learning about the role of non-steroidal MRAs in the latest treatment recommendations of the management
on CKD in Type 2 Diabetes, including ADA, KDIGO and the focused update of the ESC Heart failure Guidelines 2023 - Translating guidelines into the daily clinical care
Deepening knowledge about outcomes of FINEARTS-HF, FIDELIO-DKD, FIGARO-DKD and FIDELITY
Understanding current treatment approaches and learning about potential future therapies of chronic heart failure, including non-steroidal MRAs
All webinars and webcasts since 2024 are available in English and also with Chinese subtitles.
 | Aachen, Germany, 26-Nov-25
|
 | Helsinki, Finland, 15-Oct-25
|
 | Aachen, Germany, 20-Aug-25
|
 | Würzburg, Germany, 23-Jul-25
|
 | Groningen, Netherlands, 25-Jun-25
|
 | Charlotte, USA, 14-May-25
|
 | Monaco, 07-Mai-2025
|
 | Padua, Italy, 12-Mar-2025
|
 | Stockholm, Sweden, 26-Feb-2025
|
 | Barcelona, Spain, 12-Feb-2025
|
This activity is supported by Bayer AG